Intracellular bacterial communities in patient with recurrent urinary tract infection caused by Staphylococcus spp and Streptococcus agalactiae: a case report and literature review

African Journal of Urology

Table 2 Reports of infectious processes caused by S. epidermidis, S. simulans, and Streptococcus agalactiae

Pathogen	Risk factor	Infection	Antibiotic Resistance	MDR	Refs.
SE	Blood malignancies, myelomas, diabetes, and hospitalized patients	Sepsis, ventriculitis, prosthetic-join infection	CIP, SYN, GEN	Yes	[25]
SE	Hospitalized patients	RTI’s, UTI’s, WI’s	PEN, TET, ERY, SXT, CEF	Yes	[26]
SE	VUR	UTI	CRO	NR	[27]
SS	Geriatric patient, ureteral and renal stones, animal exposure	UTI	Fluoroquinolones	NR	[28]
SS	Geriatric patient	Pleural empyema	AMS, CEF, CIP, OXA, TET	Yes	[29]
SS	Elderly, animal exposure	Abscess, osteomyelitis foot	AMP, CIP, CLI, OXA, PEN, CRO	Yes	[30]
SGB	Diabetes	UTI’s	TET, CIP	No	[31]
SGB	Pregnant women, HIV, diabetes	UTI’s, none	CRO, ERY, CIP, CLI, TET	Yes	[32]
SGB	None and catheterized patients	UTI’s	Macrolides, LVX, TET	Yes	[33]

SE Staphylococcus epidermidis, SS Staphylococcus simulans, SGB Streptococcus group B, RTI’s Respiratory tract infection, UTI’s Urinary tract infections, WI’s Wound infection, VUR Vesicoureteral reflux, MDR Multidrug resistance, CIP Ciprofloxacin, SYN Synercid, GM Gentamicin, PEN Penicillin, TET Tetracycline, ERY Erythromycin, SXT Cotrimoxazole, CEF Cefazolin, CRO Ceftriaxone, AMS Ampicillin/Sulbactam, OXA Oxacillin, CLI Clindamycin, LVX Levofloxacin